Aithal GP - Search Results

1

A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers.

Whitfield JB, Schwantes-An TH, Darlay R, Aithal GP, Atkinson SR, Bataller R, Botwin G, Chalasani NP, Cordell HJ, Daly AK, Day CP, Eyer F, Foroud T, Gleeson D, Goldman D, Haber PS, Jacquet JM, Liang T, Liangpunsakul S, Masson S, Mathurin P, Moirand R, McQuillin A, Moreno C, Morgan MY, Mueller S, Müllhaupt B, Nagy LE, Nahon P, Nalpas B, Naveau S, Perney P, Pirmohamed M, Seitz HK, Soyka M, Stickel F, Thompson A, Thursz MR, Trépo E, Morgan TR, Seth D; GenomALC Consortium. Whitfield JB, et al. Among authors: aithal gp. J Hepatol. 2022 Feb;76(2):275-282. doi: 10.1016/j.jhep.2021.10.005. Epub 2021 Oct 14. J Hepatol. 2022. PMID: 34656649 Free PMC article.

2

CYP2C9 polymorphism and warfarin dose requirements.

Daly AK, Day CP, Aithal GP. Daly AK, et al. Among authors: aithal gp. Br J Clin Pharmacol. 2002 Apr;53(4):408-9. doi: 10.1046/j.1365-2125.2002.01572_6.x. Br J Clin Pharmacol. 2002. PMID: 11966680 Free PMC article. No abstract available.

3

Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity.

Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JB, Alexander G, Kenna JG, Caldwell J, Day CP. Aithal GP, et al. Hepatology. 2004 May;39(5):1430-40. doi: 10.1002/hep.20205. Hepatology. 2004. PMID: 15122773

4

Genetic regulation of warfarin metabolism and response.

Daly AK, Aithal GP. Daly AK, et al. Among authors: aithal gp. Semin Vasc Med. 2003 Aug;3(3):231-8. doi: 10.1055/s-2003-44458. Semin Vasc Med. 2003. PMID: 15199455 Review.

5

Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism.

King BP, Khan TI, Aithal GP, Kamali F, Daly AK. King BP, et al. Among authors: aithal gp. Pharmacogenetics. 2004 Dec;14(12):813-22. doi: 10.1097/00008571-200412000-00004. Pharmacogenetics. 2004. PMID: 15608560

6

Fracture risk in people with primary biliary cirrhosis: a population-based cohort study.

Solaymani-Dodaran M, Card TR, Aithal GP, West J. Solaymani-Dodaran M, et al. Among authors: aithal gp. Gastroenterology. 2006 Dec;131(6):1752-7. doi: 10.1053/j.gastro.2006.09.012. Epub 2006 Sep 8. Gastroenterology. 2006. PMID: 17087953

7

Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.

Daly AK, Aithal GP, Leathart JB, Swainsbury RA, Dang TS, Day CP. Daly AK, et al. Among authors: aithal gp. Gastroenterology. 2007 Jan;132(1):272-81. doi: 10.1053/j.gastro.2006.11.023. Epub 2006 Nov 17. Gastroenterology. 2007. PMID: 17241877

8

Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study.

Jackson H, Solaymani-Dodaran M, Card TR, Aithal GP, Logan R, West J. Jackson H, et al. Among authors: aithal gp. Hepatology. 2007 Oct;46(4):1131-7. doi: 10.1002/hep.21795. Hepatology. 2007. PMID: 17685473

9

Nonsteroidal anti-inflammatory drug-induced hepatotoxicity.

Aithal GP, Day CP. Aithal GP, et al. Clin Liver Dis. 2007 Aug;11(3):563-75, vi-vii. doi: 10.1016/j.cld.2007.06.004. Clin Liver Dis. 2007. PMID: 17723920 Review.

10

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.

Guha IN, Parkes J, Roderick P, Chattopadhyay D, Cross R, Harris S, Kaye P, Burt AD, Ryder SD, Aithal GP, Day CP, Rosenberg WM. Guha IN, et al. Among authors: aithal gp. Hepatology. 2008 Feb;47(2):455-60. doi: 10.1002/hep.21984. Hepatology. 2008. PMID: 18038452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

300 results

Search Page